Recurrent Nonsmall Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Recurrent Nonsmall Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC) (NCT03004105) | M.D. Anderson Cancer Center | 2018-05-01 |
Track Recurrent Nonsmall Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.